FABP4 Antibody [H23L13]

Catalog No.: F7853

Application: Reactivity: Human, Mouse, Rat

Lane 1: Mouse brown adipose, Lane 2: Rat brown adipose

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000

Application
WB

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
15 kDa

Datasheet & SDS

生物学的記述

Specificity
FABP4 Antibody [H23L13] detects endogenous levels of total FABP4 protein.

Clone
H23L13

Synonym(s)
Fatty acid-binding protein, adipocyte;Adipocyte lipid-binding protein (ALBP);Adipocyte-type fatty acid-binding protein (A-FABP; AFABP);Fatty acid-binding protein 4;FABP4

Background
Fatty acid–binding protein 4 (FABP4), also known as adipocyte fatty acid–binding protein (A‑FABP or aP2), is a small cytoplasmic lipid chaperone of the FABP family that is predominantly expressed in adipocytes and macrophages and functions as a major intracellular carrier of long‑chain fatty acids and other hydrophobic ligands. The protein binds fatty acids with high affinity, shuttles them between membranes and enzymes, and modulates the availability of lipid species for metabolic, signaling, and inflammatory pathways, including lipolysis‑driven release, β‑oxidation, and eicosanoid production. FABP4 influences PPARγ activity and adipogenic gene programs, and in macrophages it contributes to lipid‑handling and proinflammatory activation, thereby linking lipid trafficking to both metabolic regulation and low‑grade inflammation (“metaflammation”). Mouse models lacking FABP4 show increased obesity on high‑fat diets yet remain protected from insulin resistance and diabetes, and FABP4‑deficient mice also exhibit reduced atherosclerosis when crossed with ApoE‑null backgrounds, indicating that FABP4 couples obesity to insulin resistance and vascular disease. Low‑expression variant in the FABP4 promoter associates with reduced risk of type 2 diabetes and coronary heart disease, and circulating FABP4 levels correlate with insulin resistance, metabolic syndrome, and cardiovascular events, acting as a systemic biomarker and effector.

Background

Fatty acid–binding protein 4 (FABP4), also known as adipocyte fatty acid–binding protein (A‑FABP or aP2), is a small cytoplasmic lipid chaperone of the FABP family that is predominantly expressed in adipocytes and macrophages and functions as a major intracellular carrier of long‑chain fatty acids and other hydrophobic ligands. The protein binds fatty acids with high affinity, shuttles them between membranes and enzymes, and modulates the availability of lipid species for metabolic, signaling, and inflammatory pathways, including lipolysis‑driven release, β‑oxidation, and eicosanoid production. FABP4 influences PPARγ activity and adipogenic gene programs, and in macrophages it contributes to lipid‑handling and proinflammatory activation, thereby linking lipid trafficking to both metabolic regulation and low‑grade inflammation (“metaflammation”). Mouse models lacking FABP4 show increased obesity on high‑fat diets yet remain protected from insulin resistance and diabetes, and FABP4‑deficient mice also exhibit reduced atherosclerosis when crossed with ApoE‑null backgrounds, indicating that FABP4 couples obesity to insulin resistance and vascular disease. Low‑expression variant in the FABP4 promoter associates with reduced risk of type 2 diabetes and coronary heart disease, and circulating FABP4 levels correlate with insulin resistance, metabolic syndrome, and cardiovascular events, acting as a systemic biomarker and effector.

References
[1] Furuhashi M. J Atheroscler Thromb. 2019 Mar 1;26(3):216-232. [2] Dahlström EH, et al. Diabetes. 2021 Oct;70(10):2391-2401.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%